Company News

Share this article:
Heritage Pharmaceuticals and Ipca Laboratories have entered in to a strategic alliance for the development, supply and marketing of generic pharmaceutical products for the US prescription drug market. Under the agreement, Ipca shall develop and register selected products for US ANDA submission and Heritage retains sales and marketing rights to such products. The parties shall share net profits from the sales proceeds post-launch. Heritage Pharmaceuticals Inc. is an emerging generic pharmaceutical company engaged in the acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the global prescription drug markets. Heritage launched its US label in 2006. Ipca Laboratories, based in Mumbai, India, is engaged in the manufacturing and marketing of a range of pharmaceuticals with a focus on international business.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.